Trovagene is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their molecular diagnostic technology and medical discipline.
“The study assessed the activity of andexanet alfa in reversing anticoagulation and reducing bleeding in a validated animal model using Daiichi Sankyo’s oral, once-daily, direct Factor Xa inhibitor edoxaban as the anticoagulant.”
Trovagene, Inc. (TrovaGene), incorporated on September 21, 2009, is a molecular diagnostic company. The Company focuses on the development and commercialization of a molecular diagnostic technology for use in disease detection and monitoring across a range of medical disciplines. [Source: Reuters]
Company Website: https://www.trovagene.com